|
Generiese naam
|
Handelsnaam/
Alternatiewe Naam
|
Aanduidings
|
vervaardiger
|
R&D-stadium
|
|
Inbakicept
|
ALT 803, N 803, Anktiva, IL-15N72D:IL-15RaSu/Fc samesmeltingsproteïenkompleks, Inbakicept, Nogapendekin alfa inbakicept
|
Kanker, bakteriële infeksie, virus infeksie
|
Shenzhen Beike Biotechnology Co., Ltd., ImmunityBio, Inc., Altor BioScience Corp.
|
Goedkeuring
|
|
NKTR-255
|
NKTR 255
|
Kanker
|
Nektarterapie
|
Fase II
|
|
RTX-240
|
RTX 212, RTX 240
|
Akute promyelositiese leukemie, akute myeloïede leukemie
|
Rubius Therapeutics, Inc.
|
Fase II
|
|
SO-C101
|
CYP 0150, CYP-0150, RLI-15, SO C101, IL-15-IL-15 reseptor α fusieproteïen, nanrilkefusp alfa, RLI, Super IL-15 sitokien
|
Kanker
|
Sotio, LLC, Merck & Co., Inc.
|
Fase II
|
|
HCW-9201
|
HCW 9201
|
Akute myeloïede leukemie, myelodisplastiese sindroom
|
HCW Biologics Inc., Washington University School of Medicine
|
Fase I/II
|
|
HCW-9218
|
HCW 9218
|
Plaaslik gevorderde pankreaskanker, vaste gewasse, limfoom, melanoom, pankreas acinêre karsinoom, pulmonale fibrose
|
HCW Biologics Inc., Universiteit van Minnesota Masonic Cancer Center
|
Fase I/II
|
|
JK-08
|
JK 08
|
Borskanker, Kolorektale Kanker, Melanoom, Tumor Metastase, Tumor, Soliede Tumor
|
Salubris Biotherapeutics, Inc.
|
Fase I/II
|
|
SHR-1501
|
SHR 1501
|
Blaaskanker, Tumore
|
Jiangsu Hengrui Pharmaceuticals Co., Ltd., SUZHOU SUNCADIA BIOPHARMACEUTICALS CO., LTD.
|
Fase I/II
|
|
ASKG-315
|
ASKG-215b, ASKG-315, ASKG-215 beta, IL-15 Fc-fusieproteïen
|
Plaaslik gevorderde kwaadaardige soliede gewasse, Metastatiese soliede gewasse, Gevorderde kwaadaardige soliede gewasse, Tumore
|
Jiangsu Aosaikang Pharmaceutical Co., Ltd., AskGene Pharma, Inc., Aosaikang Pharmaceutical Co. Ltd.
|
Fase I
|
|
ASKG-915
|
ASKG 915
|
Vaste gewasse, gewasse
|
AskGene Pharma, Inc.
|
Fase I
|
|
BJ-001
|
BJ 001
|
Vaste gewasse, aansteeklike siektes, infeksies
|
BJ Bioscience Inc.
|
Fase I
|
|
CALY-002
|
CALY002
|
Coeliakie, Eosinofiele esofagitis, Outo-immuun siektes
|
Calypso Biotech BV
|
Fase I
|
|
EQ-102
|
BNZ 2, EQ 102
|
Coeliakie
|
Bioniz Therapeutics, Inc., Equillium, Inc.
|
Fase I
|
|
Heterodimeriese interleukien 15
|
hetIL-15, IL 15, NIZ985, sIL 15Ra, Heterodimeriese IL-15
|
Limfoom, vaste gewasse
|
Novartis Pharma AG
|
Fase I
|
|
KD-033
|
KD 033, Anti-mens-PD-L1-IL-15 bispesifieke proteïen, Bi-funksionele anti-PD-L1/IL-15 samesmeltingsproteïen
|
Soliede gewasse
|
Kadmon Holdings, Inc.
|
Fase I
|
|
OBX-115
|
OBX 115, sitoTIL 15, sitoTIL 15, IL15CA2 DRD gemodifiseerde T-selle
|
Melanoom, vaste gewasse
|
Obsidian Therapeutics, Inc., Anderson Universiteit, Die Universiteit van Texas MD Anderson Cancer Center
|
Fase I
|
|
PF-07209960
|
Hangende opdatering
|
Kanker
|
Pfizer Inc.
|
Fase I
|
|
QL415
|
QL 415, QL-415, QL415
|
gewas
|
QLSF Bioterapeutika
|
Fase I
|
|
Rekombinante menslike interleukien 15
|
Hangende opdatering
|
Soliede gewasse
|
Beijing Kawin Technology Share-Holding Co., Ltd
|
Fase I
|
|
Rekombinante interleukien 15
|
Hangende opdatering
|
Hangende opdatering
|
Beijing Kawin Technology Share-Holding Co., Ltd
|
Fase I
|
|
RPTR-147
|
Hangende opdatering
|
Melanoom, limfoom, papillomavirus infeksie, vaste gewasse
|
Repertorium Immune Medicines, Inc.
|
Fase I
|
|
RPTR-147-1
|
RPTR147 1
|
Soliede gewasse
|
Repertorium Immune Medicines, Inc.
|
Fase I
|
|
SAL-008
|
JK08, SAL-008
|
Vaste gewasse, gewasse
|
Suzhou Genemen Biotech. Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd.
|
Fase I
|
|
SIM-237
|
SIM-0237, SIM0237
|
Soliede gewasse
|
Jiangsu Simcere Pharmaceutical Co., Ltd.
|
Fase I
|
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
GEEN
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
